Europe Cannabis Industry & Marijuana Business News

German pharmacies have new pharmaceutical CBD supplier

The medical cannabidiol market is becoming more competitive in Germany, as 2020 kicks off with one new CBD option that pharmacists can dispense to patients. A Cologne, Germany-based distributor of medical cannabis started offering pure CBD in kits with which pharmacists can compound preparations according to a doctor’s prescription. The kits allow pharmacists to prepare […]

Read More

Aphria One, Brampton subsidiary receive EU-GMP certifications, clearing way for European cannabis exports

Aphria has received its first two essential European quality standard certifications, which the Canadian medical cannabis producer says will allow it to export finished dried flower and oil in bulk to European Union countries with established medical marijuana regimes. The company earned a certificate of EU-Good Manufacturing Practice (GMP) compliance on Jan. 15 for its […]

Read More

European Commission falls short on WHO cannabis recommendations, experts say

The European Commission’s proposal that European Union-member countries support three of the six World Health Organization (WHO) cannabis scheduling recommendations does not merit much celebration from the cannabis industry, according to international drug policy experts. “The only good point in the draft’s common position is that the EU should support the deletion of cannabis from Schedule IV, but […]

Read More

Product supply interruptions hit German medical cannabis market, but government dismisses risk of shortages

Supply disruptions are rippling through Germany’s growing medical cannabis market, but the country’s federal government says there are no signs at the moment of widespread product shortages. In response to a recent parliamentary inquiry, the government noted that pharmacies that sell medical cannabis have access to a variety of distributors beyond some companies whose products […]

Read More

European Commission proposes unified EU vote on WHO cannabis scheduling recommendations

In advance of the March session of the United Nations Commission on Narcotic Drugs (CND), the European Union’s executive branch has proposed that EU member nations vote in favor of three of the six World Health Organization (WHO) cannabis scheduling recommendations. The European Commission “Proposal for a Council Decision” is meaningful because – if adopted by […]

Read More

GW Pharma beats projections with $108M in Q4 sales thanks to CBD drug

A popular cannabis-derived epilepsy treatment is increasing sales for a London company making pharmaceutical treatments from marijuana. London-based GW Pharmaceuticals told investors Monday that it rang up $108 million in sales last quarter and $309 million for calendar 2019. The company’s fourth-quarter sales beat consensus analyst expectations of $102.4 million. GW attributed the sales figures to physicians […]

Read More

Israel’s Canndoc signs deal with Tilray to import medical cannabis

Israel-based Canndoc has entered into an agreement to import 2.5 tons of medical cannabis into Israel to address the supply shortage in that country. The cannabis will originate from Canadian producer Tilray’s facility in Portugal, the company said in a news release. The first shipment is expected to arrive early this month. As part of […]

Read More

Top 10 global cannabis stories of 2019: WHO backs rescheduling, Linton out at Canopy, Canadian firms eye US & more

Cannabis markets in Canada and elsewhere in the world went on a roller-coaster ride in 2019, as irrational expectations gave way to more realistic market assessments. Global medical marijuana markets, corporations and top executives experienced breakthroughs and setbacks this past year. That’s the gist of the 10 most widely read business stories carried by Marijuana Business Daily […]

Read More

Greece’s new government committed to cannabis sector success: Q&A with Pelopidas Kalliris of Ministry of Development and Investment

Greece is one of a half-dozen European countries hoping to cash in on medical cannabis exports. The country is also developing rules for domestic patients to access medical marijuana. Because Greece was among the first countries to allow medical cannabis cultivation in Europe, it already has attracted more than 100 companies in the application process seeking […]

Read More

Analysis: Germany’s medical cannabis market loses momentum but on pace to surpass 100 million euros

Insurance reimbursements for medical cannabis in Germany reached a new high during the July-September period, according to recently published data by the German National Association of Statutory Health Insurance Funds (GKV-Spitzenverband). However, the data also suggests that growth in medical marijuana sales is losing momentum as double-digit gains in MMJ reimbursements become harder to maintain. Statutory health insurance reimbursements […]

Read More

Italy to nearly triple domestic medical cannabis production in 2020

The Italian Ministry of Health plans to almost triple the quantity of medical marijuana to be produced domestically in the coming year. This signals the intention of the government to rely to a lesser degree on imports in 2020 to serve growing domestic demand for medical cannabis. As per the country’s psychotropic substances quota, which covers medical cannabis, the […]

Read More